SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-054157
Filing Date
2024-04-29
Accepted
2024-04-29 17:06:25
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2412907d1_10ka.htm   iXBRL 10-K/A 333358
2 EXHIBIT 31.3 tm2412907d1_ex31-3.htm EX-31.3 4301
3 EXHIBIT 31.4 tm2412907d1_ex31-4.htm EX-31.4 3888
  Complete submission text file 0001104659-24-054157.txt   612338

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mist-20231231.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20231231_lab.xml EX-101.LAB 36884
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20231231_pre.xml EX-101.PRE 24160
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2412907d1_10ka_htm.xml XML 6579
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38899 | Film No.: 24892479
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)